查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1830952

主動脈支架移植物市場

Aortic Stent Grafts Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5個工作天內

價格
簡介目錄

主動脈支架移植物市場預計將從 2024 年的 26.2 億美元擴大到 2031 年的 40.3 億美元，預計 2025 年至 2031 年的複合年成長率為 6.5%。

市場洞察與分析師觀點：支架移植物是一種專門用於治療主動脈瘤的醫療器械，採用微創血管內技術。該裝置由一層薄金屬網（稱為支架）組成，金屬網外包裹著一層薄聚酯纖維（稱為移植物）。支架經由導管插入主動脈並定位。一旦定位，支架移植物就會保持固定，允許血液流過，從而保護受影響的主動脈部分並防止動脈瘤破裂。主動脈瘤發生率的上升以及對血管內修復等微創手術的日益青睞是推動主動脈支架移植物市場成長的關鍵因素。然而，市場參與者的產品召回對市場擴張構成了挑戰。此外，預計技術進步和製造商的策略性舉措將在不久的將來為主動脈支架移植物市場帶來新的趨勢。

成長促進因素：醫學科技的進步推動了微創設備的發展，這些設備以創傷較小或非侵入性的替代方法取代了傳統的、痛苦的手術方法。微創技術在外科領域越來越受歡迎，包括心臟外科。血管內動脈瘤修復術 (EVAR) 是一種治療腹主動脈瘤的微創方法，透過比開胸心臟手術更小的切口將支架移植物插入主動脈受影響的區域，從而促進更快癒合並縮短手術時間。 JAMA Network 於 2022 年 5 月發表的一項研究比較了 EVAR 與 AAA 的開放性修復的長期結果，顯示血管內修復比開放修復腹主動脈瘤的風險更低。此外，外科醫生因其優勢而採用微創技術，醫療設備和外科手術技術的進步也促進了其更廣泛的接受。因此，醫療機構正在投資培訓醫護人員併購置必要的設備，以滿足對選擇性主動脈瘤修復手術日益成長的需求，從而增強患者的治療選擇和整體醫療保健體驗。

因此，對微創設備日益成長的需求是主動脈支架移植市場成長的重要驅動力。

戰略洞察

報告細分和範圍：「2031 年全球主動脈支架移植物市場分析」透過研究以下細分進行：產品類型和最終用戶。

細分分析：依產品類型，市場分為腹主動脈支架移植物和胸主動脈支架移植物。 2023年，腹主動脈支架移植物佔據主動脈支架移植物市場的最大佔有率。

就最終用戶而言，市場分為醫院和門診手術中心。由於專業且複雜的科學儀器的普及，預計醫院領域將在2023年至2031年期間佔據相當大的市場佔有率。

區域分析：全球主動脈支架移植市場報告涵蓋北美、歐洲、亞太、南美和中美以及中東和非洲。

就收入而言，2023 年北美佔據主動脈支架移植物市場的首位。由於吸菸者數量眾多且人們強烈傾向於微創手術，主動脈瘤的盛行率不斷上升，加上美國優惠的報銷政策和不斷上漲的醫療支出，這些都是推動該地區市場成長的關鍵因素。例如，美國疾病管制與預防中心 (CDC) 於 2021 年 9 月發布的資料顯示，吸菸史約佔腹主動脈瘤的 75%，美國預防服務工作小組建議有吸菸史的 65 歲及以上男性接受腹主動脈瘤超音波篩檢，即使沒有症狀。此外，血管外科學會 (SVS) 報告稱，美國每年約有 20 萬人被診斷出患有 AAA。因此，人群中主動脈瘤等心血管疾病發生率的不斷增加推動了美國對主動脈支架移植的需求，促進了主動脈支架移植市場的成長。

主動脈支架移植物市場報告範圍

產業發展與未來機會：主動脈支架移植物市場的預測可以幫助利害關係人規劃其成長策略。根據主要市場參與者的新聞稿，以下是一些重點舉措：

2023年9月，微創心脈科技旗下三款主動脈介入產品獲得泰國食品藥物管理局（TFDA）批准，包括Castor分支型主動脈覆膜支架及輸送系統、Minos腹主動脈覆膜支架及輸送系統以及Hercules低剖面胸主動脈覆膜支架系統，用於治療胸主動脈和腹主動脈疾病，目前已在泰國註冊。

2023年3月，Bolton Medical, Inc. 的 RelayPro 胸主動脈支架移植物系統獲得美國食品藥品監督管理局 (FDA) 批准，該系統包含一根輸送導管和由鎳鈦合金、聚酯和鉑銥合金製成的管狀植入物，用於修復主動脈損傷，尤其是降主動脈損傷。 2023年3月，Vector Biolabs 宣布完成設施擴建，其中包括辦公空間、倉庫、品管實驗室和無塵室生產套件。該公司表示，新增產能將使其能夠隨著需求成長保持快速反應，並擴展其服務範圍，包括新產品表徵和品質控制服務。

2021年5月，Endologix LLC在獲得加拿大衛生部批准後，在加拿大推出了ALTO腹部支架移植物，該產品也已在阿根廷獲得商業批准。此次上市旨在提升公司在全球市場的影響力。競爭格局與主要公司：主動脈支架移植物市場的主要參與者包括ENDOLOGIX INC、Terumo Corporation、Radcliffe Medical Media、Cook、MicroPort Scientific Corporation、Corcym、LeMaitre Vascular, Inc、WL Gore & Associates, Inc.、JOTEC GmbH和美敦力。這些公司專注於開發新技術、改進現有產品並拓展地理範圍，以滿足日益成長的全球消費者需求並拓寬其特色產品組合。

目錄

第1章：簡介

第 2 章：執行摘要

  • 關鍵見解
  • 市場吸引力分析

第3章：研究方法

第4章：主動脈支架移植物市場格局

  • 概述
  • PEST分析
  • 生態系分析
    • 價值鏈中的供應商列表

第5章：主動脈支架移植市場－關鍵市場動態

  • 關鍵市場促進因素
  • 主要市場限制因素
  • 關鍵市場機會
  • 未來趨勢
  • 促進因素和限制因素的影響分析

第6章：主動脈支架移植市場－全球市場分析

  • 主動脈支架移植物 - 全球市場概覽
  • 主動脈支架移植物－全球市場及2031年預測

第7章：主動脈支架移植物市場－收入分析－依產品，2021-2031

  • 概述
  • 腹主動脈支架移植物
  • 胸主動脈覆膜支架

第 8 章：主動脈支架移植物市場 - 收入分析 - 按最終用戶，2021-2031 年

  • 概述
  • 醫院
  • 門診手術中心

第9章：主動脈支架移植物市場－收入分析，2021-2031－地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 英國
    • 歐洲其他地區
  • 亞太
    • 澳洲
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第10章：產業格局

  • 併購
  • 協議、合作、合資企業
  • 新產品發布
  • 擴張和其他策略發展

第 11 章：競爭格局

  • 關鍵參與者的熱圖分析
  • 公司定位與集中度

第 12 章：主動脈支架移植物市場 - 關鍵公司簡介

  • Endologix Inc
  • Terumo Corporation
  • Radcliffe Medical Media
  • MicroPort Scientific Corporation
  • Corcym
  • LeMaitre Vascular, Inc
  • W. L. Gore & Associates, Inc
  • JOTEC GmbH
  • Medtronic

第 13 章：附錄

簡介目錄
Product Code: TIPHE100000878

The aortic stent grafts market is anticipated to expand from US$ 2.62 billion in 2024 to US$ 4.03 billion by 2031, with a projected CAGR of 6.5% from 2025 to 2031.

Market Insights and Analyst Perspective:A stent graft is a specialized medical device intended for the treatment of aortic aneurysms using minimally invasive endovascular techniques. This device consists of a thin metal mesh known as the stent, which is covered by a thin polyester fabric referred to as the graft. It is introduced via a catheter and positioned within the aorta. Once positioned, the stent graft remains fixed, allowing blood to flow through it, thereby safeguarding the affected section of the aorta and preventing aneurysm rupture. The rising incidence of aortic aneurysms and the growing preference for minimally invasive procedures like endovascular repairs are key factors propelling the growth of the aortic stent grafts market. However, product recalls by market players pose challenges to market expansion. Additionally, advancements in technology and strategic initiatives by manufacturers are expected to introduce new trends in the aortic stent grafts market in the near future.

Factors Driving Growth:Advancements in medical science and technology have led to the development of minimally invasive devices, which replace traditional, painful surgical methods with less invasive or noninvasive alternatives. Minimally invasive techniques have become increasingly popular in surgical disciplines, including cardiac surgery. Endovascular aneurysm repair (EVAR) is a minimally invasive approach for treating abdominal aortic aneurysms, performed by inserting a stent graft into the affected area of the aorta through a smaller incision than that required for open cardiac surgery, thus promoting quicker healing and reducing procedure duration. A study published by JAMA Network in May 2022 compared the long-term outcomes of EVAR with open repair of AAA, indicating that endovascular repair carries a lower risk than open repair for abdominal aortic aneurysms. Furthermore, surgeons are adopting minimally invasive techniques due to their advantages, and improvements in medical devices and surgical expertise have facilitated broader acceptance. Consequently, healthcare institutions are investing in training their medical personnel and acquiring the necessary equipment to address the rising demand for elective aortic aneurysm repair surgeries, thereby enhancing treatment options and overall healthcare experiences for patients.

Thus, the growing demand for minimally invasive devices is a significant driver of the aortic stent grafts market growth.

Strategic Insights

Report Segmentation and Scope:The "global aortic stent grafts market analysis to 2031" has been conducted by examining the following segments: product type and end user.

Segmental Analysis:By product type, the market is divided into abdominal aortic and thoracic aortic stent grafts. The abdominal aortic stent graft segment accounted for the largest share of the aortic stent grafts market in 2023.

Regarding end users, the market is categorized into hospitals and ambulatory surgical centers. The hospital segment is expected to capture a significant market share from 2023 to 2031, due to the availability of specialized and complex scientific instruments.

Regional Analysis:The global aortic stent grafts market report encompasses North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.

In terms of revenue, North America led the aortic stent grafts market in 2023. The increasing prevalence of aortic aneurysms, attributed to a high number of smokers and a strong preference for minimally invasive procedures, along with favorable reimbursement policies and rising healthcare expenditures in the US, are key factors driving market growth in the region. For example, data from the Centers for Disease Control and Prevention (CDC) published in September 2021 indicates that a history of smoking accounts for approximately 75% of abdominal aortic aneurysms, and men aged 65 and older with a smoking history are advised to undergo abdominal aortic aneurysm ultrasound screening, even if asymptomatic, by the U.S. Preventive Services Task Force. Additionally, the Society for Vascular Surgery (SVS) reports that around 200,000 individuals are diagnosed with AAA in the US annually. Therefore, the increasing incidence of cardiovascular issues such as aortic aneurysms among the population is driving the demand for aortic stent grafts in the US, facilitating the growth of the aortic stent grafts market.

Aortic Stent Grafts Market Report Scope

Industry Developments and Future Opportunities:The forecast for the aortic stent grafts market can assist stakeholders in planning their growth strategies. According to press releases from key market players, several initiatives are highlighted below:

In September 2023, MicroPort Endovastec received approval from the Thailand Food and Drug Administration (TFDA) for three aortic intervention products, including the Castor Branched Aortic Stent-Graft and Delivery System, the Minos Abdominal Aortic Stent-Graft and Delivery System, and the Hercules Thoracic Stent Graft System with Low Profile Delivery System. These products are designed to treat thoracic and abdominal aortic diseases and are now registered for use in Thailand.

In March 2023, Bolton Medical, Inc. obtained U.S. Food & Drug Administration (FDA) approval for its RelayPro Thoracic Stent-Graft System, which includes a delivery catheter and tube-shaped implants made of nitinol, polyester, and platinum-iridium, used for repairing damage in the aorta, particularly in the descending thoracic aorta.In March 2023, Vector Biolabs announced the completion of a facility expansion, which includes office space, warehouses, QC labs, and a cleanroom manufacturing suite. The company stated that this additional capacity will enable it to maintain fast response times as demand grows and expand its offerings to include new product characterization and quality control services.

In May 2021, Endologix LLC launched the ALTO Abdominal Stent Graft in Canada after receiving approval from Health Canada, and it has also been commercially approved in Argentina. This launch aims to enhance the company's global presence in the market.Competitive Landscape and Key Companies:Key players in the aortic stent grafts market include ENDOLOGIX INC, Terumo Corporation, Radcliffe Medical Media, Cook, MicroPort Scientific Corporation, Corcym, LeMaitre Vascular, Inc, W. L. Gore & Associates, Inc., JOTEC GmbH, and Medtronic. These companies are focused on developing new technologies, enhancing existing products, and expanding geographically to meet the growing global consumer demand and broaden their specialty product portfolios.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Definition, Assumptions and Limitations
  • 1.3 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness Analysis

3. Research Methodology

4. Aortic Stent Grafts Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Ecosystem Analysis
    • 4.3.1 List of Vendors in the Value Chain

5. Aortic Stent Grafts Market - Key Market Dynamics

  • 5.1 Key Market Drivers
  • 5.2 Key Market Restraints
  • 5.3 Key Market Opportunities
  • 5.4 Future Trends
  • 5.5 Impact Analysis of Drivers and Restraints

6. Aortic Stent Grafts Market - Global Market Analysis

  • 6.1 Aortic Stent Grafts - Global Market Overview
  • 6.2 Aortic Stent Grafts - Global Market and Forecast to 2031

7. Aortic Stent Grafts Market - Revenue Analysis (USD Million) - By Product, 2021-2031

  • 7.1 Overview
  • 7.2 Abdominal Aortic Stent Grafts
  • 7.3 Thoracic Aortic Stent Grafts

8. Aortic Stent Grafts Market - Revenue Analysis (USD Million) - By End User, 2021-2031

  • 8.1 Overview
  • 8.2 Hospitals
  • 8.3 Ambulatory Surgical Centers

9. Aortic Stent Grafts Market - Revenue Analysis (USD Million), 2021-2031 - Geographical Analysis

  • 9.1 North America
    • 9.1.1 North America Aortic Stent Grafts Market Overview
    • 9.1.2 North America Aortic Stent Grafts Market Revenue and Forecasts to 2031
    • 9.1.3 North America Aortic Stent Grafts Market Revenue and Forecasts and Analysis - By Product
    • 9.1.4 North America Aortic Stent Grafts Market Revenue and Forecasts and Analysis - By End User
    • 9.1.5 North America Aortic Stent Grafts Market Revenue and Forecasts and Analysis - By Countries
      • 9.1.5.1 United States Aortic Stent Grafts Market
        • 9.1.5.1.1 United States Aortic Stent Grafts Market, by Product
        • 9.1.5.1.2 United States Aortic Stent Grafts Market, by End User
      • 9.1.5.2 Canada Aortic Stent Grafts Market
        • 9.1.5.2.1 Canada Aortic Stent Grafts Market, by Product
        • 9.1.5.2.2 Canada Aortic Stent Grafts Market, by End User
      • 9.1.5.3 Mexico Aortic Stent Grafts Market
        • 9.1.5.3.1 Mexico Aortic Stent Grafts Market, by Product
        • 9.1.5.3.2 Mexico Aortic Stent Grafts Market, by End User
  • 9.2 Europe
    • 9.2.1 Germany
    • 9.2.2 France
    • 9.2.3 Italy
    • 9.2.4 Spain
    • 9.2.5 United Kingdom
    • 9.2.6 Rest of Europe
  • 9.3 Asia-Pacific
    • 9.3.1 Australia
    • 9.3.2 China
    • 9.3.3 India
    • 9.3.4 Japan
    • 9.3.5 South Korea
    • 9.3.6 Rest of Asia-Pacific
  • 9.4 Middle East and Africa
    • 9.4.1 South Africa
    • 9.4.2 Saudi Arabia
    • 9.4.3 U.A.E
    • 9.4.4 Rest of Middle East and Africa
  • 9.5 South and Central America
    • 9.5.1 Brazil
    • 9.5.2 Argentina
    • 9.5.3 Rest of South and Central America

10. Industry Landscape

  • 10.1 Mergers and Acquisitions
  • 10.2 Agreements, Collaborations, Joint Ventures
  • 10.3 New Product Launches
  • 10.4 Expansions and Other Strategic Developments

11. Competitive Landscape

  • 11.1 Heat Map Analysis by Key Players
  • 11.2 Company Positioning and Concentration

12. Aortic Stent Grafts Market - Key Company Profiles

  • 12.1 Endologix Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Terumo Corporation
  • 12.3 Radcliffe Medical Media
  • 12.4 MicroPort Scientific Corporation
  • 12.5 Corcym
  • 12.6 LeMaitre Vascular, Inc
  • 12.7 W. L. Gore & Associates, Inc
  • 12.8 JOTEC GmbH
  • 12.9 Medtronic

13. Appendix

  • 13.1 Glossary
  • 13.2 About The Insight Partners
  • 13.3 Market Intelligence Cloud